نتائج البحث - Stella, Peter

Pharmaceutical pricing, cost containment and new treatments for rare diseases in children حسب Stella, Peter, Gold-von Simson, Gabrielle

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Prediction of Resuscitation for Pediatric Sepsis from Data Available at Triage حسب Stella, Peter, Haines, Elizabeth, Aphinyanaphongs, Yindalon

احصل على النص الكامل احصل على النص الكامل

Insulin Glargine 300 U/mL and Insulin Glulisine Treatment in Patients with Type 2 Diabetes: A Non-Interventional Study of Effectiveness in Routine Clinical Practice حسب Hidvégi, Tibor, Balogh, Zoltán, Vass, Viktor, Kovács, Gábor, Stella, Péter

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL in People with Type 1 Diabetes on Basal–Bolus Insulin: Phase 4 OPTIMIZE Study حسب Mathieu, Chantal, Weisnagel, S. John, Stella, Peter, Bruhwyler, Jacques, Alexandre, Kathy

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Association of Patient Profile with Glycemic Control and Hypoglycemia with Insulin Glargine 300 U/mL in Type 2 Diabetes: A Post Hoc Patient-Level Meta-Analysis حسب Twigg, Stephen M., Escalada, Javier, Stella, Peter, Merino-Trigo, Ana, Lavalle-Gonzalez, Fernando J., Cariou, Bertrand, Meneghini, Luigi F.

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Validation of parsimonious prognostic models for patients infected with COVID-19 حسب Harish, Keerthi, Zhang, Ben, Stella, Peter, Hauck, Kevin, Moussa, Marwa M, Adler, Nicole M, Horwitz, Leora I, Aphinyanaphongs, Yindalon

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe and the USA حسب Mauricio, Dídac, Meneghini, Luigi, Seufert, Jochen, Liao, Laura, Wang, Hongwei, Tong, Liyue, Cali, Anna, Stella, Peter, Carita, Paulo, Khunti, Kamlesh

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Treatment Dosing Patterns and Clinical Outcomes for Patients with Type 2 Diabetes Starting or Switching to Treatment with Insulin Glargine (300 Units per Milliliter) in a Real-Worl... حسب Gupta, Shaloo, Wang, Hongwei, Skolnik, Neil, Tong, Liyue, Liebert, Ryan M., Lee, Lulu K., Stella, Peter, Cali, Anna, Preblick, Ronald

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

The effect of concomitant DPPIVi use on glycaemic control and hypoglycaemia with insulin glargine 300 U/mL (Gla-300) versus insulin glargine 100 U/mL (Gla-100) in people with type... حسب Yale, Jean-François, Pettus, Jeremy Hodson, Brito-Sanfiel, Miguel, Lavalle-Gonzalez, Fernando, Merino-Trigo, Ana, Stella, Peter, Chevalier, Soazig, Buzzetti, Raffaella

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Efficacy and Safety of iGlarLixi, Fixed-Ratio Combination of Insulin Glargine and Lixisenatide, Compared with Basal-Bolus Regimen in Patients with Type 2 Diabetes: Propensity Score... حسب Tabák, Ádám G., Anderson, John, Aschner, Pablo, Liu, Minzhi, Saremi, Aramesh, Stella, Peter, Tinahones, Francisco J., Wysham, Carol, Meier, Juris J.

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice‐daily basal insulin to once‐daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (ED... حسب Roussel, Ronan, d'Emden, Michael C., Fisher, Miles, Ampudia‐Blasco, F. Javier, Stella, Peter, Bizet, Florence, Cali, Anna M. G., Wysham, Carol H.

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real‐world setting حسب Meneghini, Luigi F., Mauricio, Didac, Orsi, Emanuela, Lalic, Nebojsa M., Cali, Anna M.G., Westerbacka, Jukka, Stella, Peter, Candelas, DEA, Christophe, Pilorget, Valerie, Perfetti, Riccardo, Khunti, Kamlesh

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Urinary NGAL Marks Cystic Disease in HIV-Associated Nephropathy حسب Paragas, Neal, Nickolas, Thomas L., Wyatt, Christina, Forster, Catherine S., Sise, Meghan, Morgello, Susan, Jagla, Bernd, Buchen, Charles, Stella, Peter, Sanna-Cherchi, Simone, Carnevali, Maria Luisa, Mattei, Silvia, Bovino, Achiropita, Argentiero, Lucia, Magnano, Andrea, Devarajan, Prasad, Schmidt-Ott, Kai M., Allegri, Landino, Klotman, Paul, D'Agati, Vivette, Gharavi, Ali G., Barasch, Jonathan

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

A validated, real-time prediction model for favorable outcomes in hospitalized COVID-19 patients حسب Razavian, Narges, Major, Vincent J., Sudarshan, Mukund, Burk-Rafel, Jesse, Stella, Peter, Randhawa, Hardev, Bilaloglu, Seda, Chen, Ji, Nguy, Vuthy, Wang, Walter, Zhang, Hao, Reinstein, Ilan, Kudlowitz, David, Zenger, Cameron, Cao, Meng, Zhang, Ruina, Dogra, Siddhant, Harish, Keerthi B., Bosworth, Brian, Francois, Fritz, Horwitz, Leora I., Ranganath, Rajesh, Austrian, Jonathan, Aphinyanaphongs, Yindalon

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل